2 ASX healthcare shares racing higher on positive updates

These healthcare shares are avoiding the market weakness on Wednesday.

| More on:
In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be falling for a fourth day in a row, but that hasn't stopped a couple of ASX healthcare shares from charging higher today.

Here's what is getting investors excited about them on Wednesday:

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price was up as much as 14% to 99 cents before easing back. The ASX healthcare share is now up 3% at 89 cents.

This has been driven by news that bisantrene shows potent anti-cancer activity when screened on a diverse panel of blood and solid organ tumour cells. Bisantrene, which is the company's lead asset, is a small-molecule anthracene chemotherapeutic.

According to the release, when used at low drug concentrations, bisantrene improved the cancer cell-killing efficacy of the widely used anti-cancer drug doxorubicin. The data further supports the potential clinical use of bisantrene in combination with doxorubicin.

Rhythm Biosciences Ltd (ASX: RHY)

The Rhythm Biosciences share price was up 15% to 34.5 cents in morning trade. It has now given back some of those gains but remains up a decent 8% to 32.5 cents.

The catalyst for this was the release of an update on its cancer diagnostics technology platform expansion program in breast cancer. The ASX healthcare share has previously used its technology to identify four biomarkers that exhibit a strong correlation with specific breast cancer subtypes.

Today's update reveals that preliminary results show that it has identified important biomarker combinations that can distinguish between patients with breast cancer and healthy controls, with an 83% sensitivity and a 90% specificity.

Management believes these encouraging results warrant confirmation in a larger sample set and justify the continuation and advancement of the project.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two doctors smile as they sit together at a desk looking at a patient's x-ray.
Healthcare Shares

Why Macquarie rates this ASX All Ords medical imaging stock a buy

The broker maintains its outperform rating on the stock.

Read more »

A man in a hospital bed on a drip gives a thumbs up sign.
Healthcare Shares

Macquarie predicts 86% upside for this ASX 200 healthcare stock

Shares could almost double over the next 12 months, according to the broker.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?

Novo Nordisk just lost $100 billion in market value.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is jumping 11% today

Let's see why investors are bidding this stock higher on Wednesday.

Read more »

stockmarket graphic in background with man looking at stockmarket on phone
Healthcare Shares

CSL shares are a buy – UBS

This expert is optimistic on what the business can achieve despite headwinds.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »